The future of the global real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets. The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the real-time PCR and digital
PCR market by product type (reagents and consumables, instruments, and
software), technology (quantitative PCR and digital PCR), application
(clinical, research, forensic, and others), end use (hospitals and diagnostic
centers, research laboratories and academic institutes, pharmaceutical and
biotechnology, clinical research organizations, forensic laboratories, and
others), and region (North America, Europe, Asia Pacific, and the Rest of the
World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market,
clinical, research, and forensic are the major segments of real-time PCR and
digital PCR market by application. Lucintel forecasts that clinical is expected
to witness highest growth over the forecast period.
Within this market,
hospital and diagnostic center will remain the largest segment due to
increasing need for qPCR and dPCR in this facility to obtain rapid and
effective disease detection and treatment.
North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.
F. Hoffmann La Roche,
Takara Bio, Becton and Dickinson, Agilent Technologies, Merck KGaA, Qiagen,
Abbott Laboratories, Thermo Fisher Scientific, Danaher, and Bio Rad
Laboratories are the major suppliers in the real-time PCR and digital PCR
market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
No comments:
Post a Comment